Published in Open Cardiovasc Med J on July 20, 2010
Enhancing complement control on endothelial barrier reduces renal post-ischemia dysfunction. J Surg Res (2011) 0.81
Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol (1992) 11.24
Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med (1992) 4.82
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science (1990) 4.67
Infectious diseases associated with complement deficiencies. Clin Microbiol Rev (1991) 4.01
Interactions of liposomes with mammalian cells. Annu Rev Biophys Bioeng (1978) 3.42
Complement-targeted therapeutics. Nat Biotechnol (2007) 3.24
The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med (1971) 2.95
Extended preservation of the liver for clinical transplantation. Lancet (1988) 2.89
Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med (1996) 2.67
Vascular ischaemia and reperfusion injury. Br Med Bull (2004) 2.28
Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation (1998) 2.14
Membrane proteins that protect against complement lysis. Springer Semin Immunopathol (1994) 1.83
Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin. J Med Chem (2006) 1.72
Probability binning comparison: a metric for quantitating univariate distribution differences. Cytometry (2001) 1.65
Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol (2003) 1.49
Complement in inflammatory tissue damage and disease. Trends Immunol (2002) 1.43
Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions. Biochemistry (1981) 1.39
Liposomes. Opportunities in drug delivery. Drugs (1997) 1.34
Design and NMR characterization of active analogues of compstatin containing non-natural amino acids. J Med Chem (2005) 1.28
Integrated computational and experimental approach for lead optimization and design of compstatin variants with improved activity. J Am Chem Soc (2003) 1.28
Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection. Immunity (2002) 1.19
Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. J Immunol (2001) 1.14
The structural basis of compstatin activity examined by structure-function-based design of peptide analogs and NMR. J Biol Chem (2002) 1.10
Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage. J Am Soc Nephrol (2006) 1.08
Spontaneous incorporation of the glycosyl-phosphatidylinositol-linked protein Thy-1 into cell membranes. Proc Natl Acad Sci U S A (1992) 1.07
Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am J Physiol (1995) 1.06
The complement system: an overview. Methods Mol Biol (2000) 1.05
Studies of structure-activity relations of complement inhibitor compstatin. J Immunol (2003) 1.04
Membrane-targeted complement inhibitors. Mol Immunol (2001) 1.03
Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. J Antimicrob Chemother (2001) 1.03
Liposomes: applications in medicine. J Biomater Appl (2001) 0.97
Therapeutic efficacy of a novel membrane-targeted complement regulator in antigen-induced arthritis in the rat. Arthritis Rheum (2000) 0.97
Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. Am J Pathol (1996) 0.93
Hierarchical costimulator thresholds for distinct immune responses: application of a novel two-step Fc fusion protein transfer method. J Immunol (2000) 0.92
Liposomal drug delivery, a novel approach: PLARosomes. Acta Biochim Pol (2000) 0.87
Complement deficiency and autoimmunity. Curr Opin Pediatr (1998) 0.87
sCR1sLe ameliorates ischemia/reperfusion injury in experimental lung transplantation. J Thorac Cardiovasc Surg (2000) 0.86
Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells. J Immunol (1998) 0.86
Tailoring anti-complement therapeutics. Biochem Soc Trans (2002) 0.84
Engrafting costimulator molecules onto tumor cell surfaces with chelator lipids: a potentially convenient approach in cancer vaccine development. J Immunol (2000) 0.84
Liposomes fuse with sperm cells and induce activation by delivery of impermeant agents. Biochim Biophys Acta (1999) 0.84
The role of complement in transplantation. Mol Immunol (2000) 0.83
Strategies for targeting complement inhibitors in ischaemia/reperfusion injury. Mol Immunol (2000) 0.83
Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x. Br J Pharmacol (1999) 0.83
Oxidizing intermediates generated in the Fenton reagent: kinetic arguments against the intermediacy of the hydroxyl radical. Environ Health Perspect (1994) 0.80
Direct energy delivery improves tissue perfusion after resuscitated shock. Surgery (2005) 0.80
Von Willebrand factor restores impaired platelet thrombogenesis in copper-deficient rats. J Nutr (1997) 0.78
Selective virus-mediated intracellular delivery of membrane-impermeant compounds by means of plasma membrane vesicles. Antiviral Res (2000) 0.78
Hepatitis B surface protein docked vesicular carrier for site specific delivery to liver. J Drug Target (2005) 0.77
Circulating immune complexes in myocardial infarction. J Clin Lab Immunol (1983) 0.77
On the ethics of facial transplantation research. Am J Bioeth (2004) 11.64
Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache (2014) 4.25
Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. J Clin Invest (2008) 4.13
Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity (2011) 3.75
Integrated 3D-printed reactionware for chemical synthesis and analysis. Nat Chem (2012) 3.23
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell (2011) 3.23
Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest (2003) 2.54
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol (2012) 2.53
Genetic characterization of H1N2 influenza A viruses isolated from pigs throughout the United States. J Clin Microbiol (2002) 2.34
Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nat Genet (2011) 2.13
Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis. Nat Med (2009) 2.10
SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res (2005) 2.07
Coding region polyadenylation generates a truncated tRNA synthetase that counters translation repression. Cell (2012) 2.06
IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J Immunol (2003) 2.03
Racial and Ethnic Disparities in Hospital Readmissions After Delivery. Obstet Gynecol (2015) 2.01
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol (2004) 2.00
Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet (2002) 1.98
Dehalococcoides mccartyi gen. nov., sp. nov., obligately organohalide-respiring anaerobic bacteria relevant to halogen cycling and bioremediation, belong to a novel bacterial class, Dehalococcoidia classis nov., order Dehalococcoidales ord. nov. and family Dehalococcoidaceae fam. nov., within the phylum Chloroflexi. Int J Syst Evol Microbiol (2012) 1.93
Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacol Sin (2002) 1.83
Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun (2004) 1.82
Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res (2003) 1.81
Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation (2006) 1.80
The magnitude of global marine species diversity. Curr Biol (2012) 1.78
Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. J Clin Invest (2015) 1.74
Stable isotope resolved metabolomics of lung cancer in a SCID mouse model. Metabolomics (2011) 1.73
Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci (2004) 1.71
Crystal structure of the FimD usher bound to its cognate FimC-FimH substrate. Nature (2011) 1.67
Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J Proteome Res (2008) 1.63
Synthesis and electromagnetic, microwave absorbing properties of core-shell Fe3O4-poly(3, 4-ethylenedioxythiophene) microspheres. ACS Appl Mater Interfaces (2011) 1.62
Transient T cell depletion causes regression of melanoma metastases. J Transl Med (2008) 1.61
Induction of regulatory T cells by physiological level estrogen. J Cell Physiol (2008) 1.59
Investigation of risk acceptance in facial transplantation. Plast Reconstr Surg (2006) 1.57
The noninvasive staging of non-small cell lung cancer: the guidelines. Chest (2003) 1.57
A novel cell segmentation method and cell phase identification using Markov model. IEEE Trans Inf Technol Biomed (2009) 1.51
Age of ovary determines remaining life expectancy in old ovariectomized mice. Aging Cell (2003) 1.50
[A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old]. Zhonghua Liu Xing Bing Xue Za Zhi (2005) 1.48
Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. J Immunol (2006) 1.47
Corticofugal modulation of initial sound processing in the brain. J Neurosci (2008) 1.46
The linker domain of the Ha-Ras hypervariable region regulates interactions with exchange factors, Raf-1 and phosphoinositide 3-kinase. J Biol Chem (2001) 1.44
Compromised small-world efficiency of structural brain networks in schizophrenic patients and their unaffected parents. Neurosci Bull (2015) 1.43
Administration of exogenous adenosine triphosphate to ischemic skeletal muscle induces an energy-sparing effect: role of adenosine receptors. J Surg Res (2012) 1.42
ARGONAUTE10 and ARGONAUTE1 regulate the termination of floral stem cells through two microRNAs in Arabidopsis. PLoS Genet (2011) 1.40
An X-chromosomal association study identifies a susceptibility locus at Xq22.1 for hepatitis B virus-related hepatocellular carcinoma. Clin Res Hepatol Gastroenterol (2013) 1.39
A Novel Combined-Catheter to Monitor Left and Right Atrial Pressures: A Simple and Reliable Method for Pediatric Cardiac Surgery. Pediatr Crit Care Med (2016) 1.39
The nuclear orphan receptor COUP-TFII plays an essential role in adipogenesis, glucose homeostasis, and energy metabolism. Cell Metab (2009) 1.38
Detecting cytokine release from single T-cells. Anal Chem (2009) 1.37
Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans. Blood (2011) 1.35
A three-dimensional carbon nanotube/graphene sandwich and its application as electrode in supercapacitors. Adv Mater (2010) 1.31
Integrin-linked kinase is a functional Mn2+-dependent protein kinase that regulates glycogen synthase kinase-3β (GSK-3beta) phosphorylation. PLoS One (2010) 1.31
Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients. Blood (2006) 1.29
Modulation of the SDF-1-CXCR4 axis by the third complement component (C3)--implications for trafficking of CXCR4+ stem cells. Exp Hematol (2006) 1.28
Integrating sensing hydrogel microstructures into micropatterned hepatocellular cocultures. Langmuir (2009) 1.24
p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.24
A novel role of complement in mobilization: immunodeficient mice are poor granulocyte-colony stimulating factor mobilizers because they lack complement-activating immunoglobulins. Stem Cells (2007) 1.23
Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11. Neoplasia (2006) 1.23
αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma. Hepatology (2013) 1.22
New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol (2012) 1.21
Dehalogenimonas lykanthroporepellens gen. nov., sp. nov., a reductively dehalogenating bacterium isolated from chlorinated solvent-contaminated groundwater. Int J Syst Evol Microbiol (2009) 1.20
Shotgun proteomics analysis of hibernating arctic ground squirrels. Mol Cell Proteomics (2009) 1.20
IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Mol Cancer (2011) 1.19
Characterizing changes in student empathy throughout medical school. Med Teach (2012) 1.19
Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis. Cancer Res (2012) 1.18
Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) regulates growth and patterning of the postnatal mouse cerebellum. Dev Biol (2008) 1.18
Facile synthesis of graphene nanosheets via Fe reduction of exfoliated graphite oxide. ACS Nano (2010) 1.17
DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial-mesenchymal transition in human breast cancer. Cancer Res (2012) 1.17
Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells. Biochem Biophys Res Commun (2002) 1.16
Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res (2009) 1.15
Diversity of Tanaidacea (Crustacea: Peracarida) in the world's oceans--how far have we come? PLoS One (2012) 1.15
Cold-induced RNA-binding proteins regulate circadian gene expression by controlling alternative polyadenylation. Sci Rep (2013) 1.14
Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction. J Pharmacol Exp Ther (2006) 1.13
Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancer. OMICS (2011) 1.13
Structure of the VirB4 ATPase, alone and bound to the core complex of a type IV secretion system. Proc Natl Acad Sci U S A (2012) 1.12
TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury. Am J Pathol (2011) 1.12
Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice. Hepatology (2013) 1.11
Blocking TLR2 activity attenuates pulmonary metastases of tumor. PLoS One (2009) 1.10
Development of an aptamer beacon for detection of interferon-gamma. Anal Chem (2010) 1.10
Design and synthesis of boronic-acid-labeled thymidine triphosphate for incorporation into DNA. Nucleic Acids Res (2007) 1.09
Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55. Cancer Res (2007) 1.09
Human stem cell grafts as therapies for motor neuron disease. Expert Opin Biol Ther (2008) 1.08
Nitric oxide inhibits autophagy in human chondrocytes: comment on the article by Sasaki et al. Arthritis Rheum (2013) 1.08
Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy. Exp Mol Pathol (2009) 1.07
Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression. PLoS One (2012) 1.07
C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and beta-glucan. J Immunol (2005) 1.07
Federal nutrition program changes and healthy food availability. Am J Prev Med (2012) 1.07
Bone marrow transplantation temporarily improves pancreatic function in streptozotocin-induced diabetes: potential involvement of very small embryonic-like cells. Transplantation (2010) 1.07
The application of Steri-Strips. Plast Reconstr Surg (2004) 1.06
Surgical and transcatheter closure of right pulmonary artery to left atrial fistula. J Card Surg (2011) 1.05
Attenuation of p38-mediated miR-1/133 expression facilitates myoblast proliferation during the early stage of muscle regeneration. PLoS One (2012) 1.05
The neurobiology of sound-specific auditory plasticity: a core neural circuit. Neurosci Biobehav Rev (2008) 1.05
Dose-response model for Listeria monocytogenes-induced stillbirths in nonhuman primates. Infect Immun (2007) 1.03
Clinical application of bidirectional Glenn shunt with off-pump technique. Asian Cardiovasc Thorac Ann (2004) 1.03
Micropatterned aptasensors for continuous monitoring of cytokine release from human leukocytes. Anal Chem (2011) 1.03
A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma. Anticancer Drugs (2012) 1.03
Modulation of gene expression in heart and liver of hibernating black bears (Ursus americanus). BMC Genomics (2011) 1.02
Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. Nat Commun (2013) 1.02